ÂÜÀòÂÒÂ×

Eric T. Williams has extensive work experience in the scientific research field. Eric T. currently holds the position of Senior Principal Scientist at Entrada Therapeutics, starting in June 2021. Before joining Entrada Therapeutics, they founded and served as the President and Chairman of the Board at Elijah's Project for Hope from January 2020. Prior to that, they worked as a Senior Scientist at Molecular Templates from October 2018 to June 2021. Eric T. also held positions at Novartis Institutes for BioMedical Research (NIBR) as an Investigator III from April 2018 to October 2018 and as an Investigator II from March 2014 to March 2018. Eric T. Williams worked as a Senior Scientist at Eisai from June 2011 to December 2013, and they were previously a Scientist at Eisai Incorporated (formerly Eisai Research Institute) from June 2008 to May 2011. Before that, they gained experience as a Postdoctoral Scientist at Eli Lilly & Co. from February 2006 to June 2008. Eric T. Williams began their career as a Graduate Research Assistant at The University of Texas Health Science Center at Houston from August 1999 to January 2006. Prior to that, they worked as a Senior Undergraduate Research Assistant at Texas A&M University from January 1996 to May 1999.

Eric T. Williams obtained their PhD in Toxicology from The University of Texas Health Science Center at Houston (UTHealth Houston) from 1999 to 2006. Prior to that, they completed their undergraduate studies at Texas A&M University, earning a BS in Biomedical Science from 1994 to 1999. Eric's education journey began at Jersey Village High School, where they completed their secondary education from 1990 to 1994.